Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
Salaroglio IC, Belisario DC, Bironzo P, Ananthanarayanan P, Ricci L, Digiovanni S, Fontana S, Napoli F, Sandri A, Facolmatà C, Libener R, Comunanza V, Grosso F, Gazzano E, Leo F, Taulli R, Bussolino F, Righi L, Papotti MG, Novello S, Scagliotti GV, Riganti C, Kopecka J. Salaroglio IC, et al. Among authors: scagliotti gv. J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7. J Exp Clin Cancer Res. 2022. PMID: 35197103 Free PMC article.
Multidrug resistance in non-small-cell lung cancer.
Scagliotti GV, Novello S, Selvaggi G. Scagliotti GV, et al. Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83. Ann Oncol. 1999. PMID: 10582146 Free article. Review.
State of the art in mesothelioma.
Scagliotti GV, Novello S. Scagliotti GV, et al. Ann Oncol. 2005;16 Suppl 2:ii240-5. doi: 10.1093/annonc/mdi703. Ann Oncol. 2005. PMID: 15958465 Free article. Review. No abstract available.
Current status of adjuvant chemotherapy in NSCLC.
Scagliotti GV, Novello S. Scagliotti GV, et al. Ann Oncol. 2006 May;17 Suppl 5:v62-3. doi: 10.1093/annonc/mdj952. Ann Oncol. 2006. PMID: 16807465 Free article. Review. No abstract available.
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.
Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV, Cambieri A, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV. Ceppi P, et al. Among authors: scagliotti gv. Ann Oncol. 2006 Dec;17(12):1818-25. doi: 10.1093/annonc/mdl300. Epub 2006 Sep 15. Ann Oncol. 2006. PMID: 16980606 Free article.
365 results